Novo Nordisk A/S

XBER:NOVA

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NOVA's stock price target?

Not Available

NOVA doesn't have any price targets made by Wall Street professionals.

What is Novo Nordisk A/S's Revenue forecast?

Projected CAGR

7%

For the last 14 years the compound annual growth rate for Novo Nordisk A/S's revenue is 12%. The projected CAGR for the next 3 years is 7%.

What is Novo Nordisk A/S's Operating Income forecast?

Projected CAGR

8%

For the last 14 years the compound annual growth rate for Novo Nordisk A/S's operating income is 13%. The projected CAGR for the next 3 years is 8%.

What is Novo Nordisk A/S's Net Income forecast?

Projected CAGR

7%

For the last 14 years the compound annual growth rate for Novo Nordisk A/S's net income is 14%. The projected CAGR for the next 3 years is 7%.